ophthamology
Novartis to file for new Lucentis indication
September 7, 2012Lucentis, Novartis, macular edema, macular oedema, ophthamology
Novartis is set to file eye treatment Lucentis for a new indication. The firm will submit Lucentis (ranibizumab) to the …
Sue NHS to ensure access to drugs, says NICE chief
August 6, 2012Lucentis, NICE, Ozurdex, judicial review, market access, ophthamology
The chairman of NICE is advising campaigners to sue NHS bodies that block a treatment recommended by the watchdog.In a …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
